Back
Nasdaq Vs. Avidity Biosciences Industry Stock Comparison
Buy
67
NDAQ
Nasdaq
Last Price:
$89.91
Seasonality Move:
5.89%
Sell
41
RNA
Avidity Biosciences
Last Price:
$34.01
Seasonality Move:
-7.29%
Sell
41
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $33.53. The Score for RNA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $33.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NDAQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.32 | Buy |
Relative Strength Index (14 RSI): | 56.97 | Buy |
Chaikin Money Flow: | 1915236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.66 - 89.74) | Buy |
Bollinger Bands (100): | (74.01 - 86.21) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.84 | Buy |
Relative Strength Index (14 RSI): | 61.49 | Buy |
Chaikin Money Flow: | 1355694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.85 - 32.05) | Buy |
Bollinger Bands (100): | (27.85 - 32.59) | Buy |
NDAQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.53 | Sell |
20-day SMA: | 88.65 | Buy |
50-day SMA: | 85.03 | Buy |
200-day SMA: | 79.11 | Buy |
8-day EMA: | 89.26 | Sell |
20-day EMA: | 88.42 | Buy |
50-day EMA: | 85.32 | Buy |
200-day EMA: | 78.38 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.38 | Buy |
20-day SMA: | 30.11 | Buy |
50-day SMA: | 30.67 | Buy |
200-day SMA: | 34.42 | Sell |
8-day EMA: | 26.71 | Buy |
20-day EMA: | 16.1 | Buy |
50-day EMA: | 7.78 | Buy |
200-day EMA: | 2.15 | Buy |
Nasdaq Earnings Growth & NDAQ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.09 per share, an increase this year of $0.45 per share, and an increase next year of $0.38 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.45 per share.
Nasdaq Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |